No Handouts for Drug Advertisements Act

Referred to the House Committee on Ways and Means.

• S 1785 Identical bill No Handouts for Drug Advertisements Act

• Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

• Ways and Means Committee
  House of Representatives

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

• MEHLMAN CONSULTING, INC.
  for THE CAMPAIGN FOR SUSTAINABLE RX PRICING · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
• COALITION FOR HEALTHCARE COMMUNICATIONS
  for COALITION FOR HEALTHCARE COMMUNICATIONS · New York · 3rd Quarter 2026 (July 1 - Sep 30)
• WHITMER & WORRALL, LLC
  for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · District of Columbia · 2nd Quarter 2026 (Apr 1 - June 30)
• MEHLMAN CONSULTING, INC.
  for THE CAMPAIGN FOR SUSTAINABLE RX PRICING · District of Columbia · 2nd Quarter 2026 (Apr 1 - June 30)
• COALITION FOR HEALTHCARE COMMUNICATIONS
  for COALITION FOR HEALTHCARE COMMUNICATIONS · New York · 2nd Quarter 2026 (Apr 1 - June 30)
• COALITION FOR HEALTHCARE COMMUNICATIONS
  for COALITION FOR HEALTHCARE COMMUNICATIONS · New York · 1st Quarter 2026 (Jan 1 - Mar 31)

Bodies those filers lobbied

• SENATE
  20 filings
• HOUSE OF REPRESENTATIVES
  16 filings
• Centers For Medicare and Medicaid Services (CMS)
  9 filings
• Health & Human Services, Dept of (HHS)
  9 filings
• White House Office
  6 filings
• Food & Drug Administration (FDA)
  4 filings
• Commerce, Dept of (DOC)
  2 filings
• Executive Office of the President (EOP)
  2 filings

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.